Xarelto (rivaroxaban) was approved by the United States Food and Drug Administration (FDA) in 2011 after a fast-track regulatory review, despite the fact that some of the agency’s own scientists had concerns about its safety.
The drug, made by Bayer and marketed by Janssen Pharmaceuticals, is a blood thinner designed to prevent blood clots and reduce the risk of stroke. It was initially approved to treat patients who have had knee or hip replacement surgery, and is also used to treat people with atrial fibrillation. Xarelto is approved for general treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Xarelto has been linked to uncontrolled internal bleeding and other serious health issues including stroke, pulmonary embolism, and brain hemorrhage. Since there is no antidote for Xarelto, bleeding events can cause serious injury or death.
Working in collaboration with other national law firms, Berman & Simmons is handling claims involving people who took Xarelto and suffered complications. There are strict statutes of limitations in dangerous drug cases, so it’s important to get in touch with us as soon as possible if you believe you have a Maine Xarelto lawsuit.